MAQC Timeline

Get e-mail updates when this information changes.

Microarrays and next-generation sequencing represent core technologies in pharmacogenomics and toxicogenomics; however, before these technologies can successfully and reliably be used in clinical practice and regulatory decision-making, standards and quality measures need to be developed. The MAQC project is helping improve the microarray and next-generation sequencing technologies and foster their proper applications in discovery, development and review of FDA regulated products. Everyone is invited to participate in the MAQC project.

• February 11, 2005: Launch of Phase I of the MAQC project (MAQC-I) on microarray technical performance
• June 5, 2006: Submission of MAQC-I manuscripts
• September 8, 2006: Publication of MAQC-I results in Nature Biotechnology [Articles freely available]
• September 8, 2006: The MAQC-I datasets are publicly available
• September 21, 2006: Launch of MAQC-II on predictive models (signatures)
• August 28, 2007: Release of “Pharmacogenomic Data Submissions — Companion Guidance”
• December 16-17, 2008: Launch of MAQC-III (or SEQC) on next-generation sequencing
• March 2009: Submission of MAQC-II manuscripts
• September 2009: Publication of MAQC-II results
• December 2009: Submission of MAQC-III manuscripts
• May 2010: Publication of MAQC-III results

 

Contact Information

Please address questions and suggestions about the MicroArray Quality Control project to the MAQC Coordinator, Dr. Leming Shi, National Center for Toxicological Research, at 870-543-7387 or Leming.Shi@fda.hhs.gov.